Selecxine

  • Biotech or pharma, therapeutic R&D
Selecxine is a bio start-up specialized in the field of immunotherapeutics to develop novel antibodies to cure various life-threatening diseases. Our lead asset, SLC-3010, is an IL-2 antibody conjugate.

Address

Seoul
South Korea

Website

http://www.selecxine.com

Contact Exhibitor


Loading
View all Partnering Companies

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS